The catalyst the market is under-weighting is the second derivative on organic billings: a steepening curve off a de-risked trough, with a bankrupt-tenant claim thrown in for free. The catalyst that broke this stock — the fiber write-downs, the dividend cut, the DISH default, ...
Read Article ›The risk-reward here is skewed favorably for a specific and unusual reason: the earnings math is more knowable than that of almost any agency, and the market is charging almost nothing for it. The category is structurally challenged and the franchise is thin — those are real, ...
Read Article ›The thesis lives in the hotels; the entertainment arm is a call option the market keeps trying to price and, I will argue, is getting wrong in a way that is more nuisance than opportunity.
Read Article ›The de-rating question the setup poses answers itself when you look closely: the stock is not down on a broken thesis but off its high in a broad healthcare drawdown, and the June quarter was a clean beat with a raise. So the honest verdict is not that McKesson is mispriced — ...
Read Article ›In the June 2026 quarter, Delta Air Lines carried the highest quarterly fuel bill in its history — total fuel expense of $4.4 billion, up nearly $2 billion year-over-year at an all-in price of $3.93 a gallon, itself a 75% jump — and still turned in an adjusted 8.8% operating m...
Read Article ›The de-rating that took the stock from the high-$40s to $42 was a repricing of dividend reliability, not of asset quality — and the assets, the balance sheet and the well inventory are all in better shape now than when the stock was higher. At a high-single-digit cash yield wi...
Read Article ›Amazon stock has slid back toward the low $240s even as AWS just posted its fastest growth in nearly four years. The bear case is simple and loud: capital spending has swallowed free cash flow. My argument is that this particular cash flow trough is the most defensible one Ama...
Read Article ›The standing critique of Rocket Lab is simple: elite growth, elite vision, no profits, and a valuation that requires everything to go right. The Iridium acquisition is the most direct possible response to that critique, because Iridium is the thing Rocket Lab has never had—a c...
Read Article ›The market spent two years treating Comcast as a structurally challenged broadband utility with a fading media albatross stapled to it, and priced it accordingly. The separation of NBCUniversal and Sky directly attacks that framing by letting a cash-rich, under-cross-sold conn...
Read Article ›Warner Bros Discovery offers a mid-to-high-teens gross return to a $31 cash takeout, backed by a buyer with unusually strong financial credibility–meanwhile the DOJ appears constructive; international approvals are accumulating; and the underlying business—particularly streami...
Read Article ›Intuit shares have been cut roughly in half from their 52-week high, recently trading in the low $300s, while Q3 fiscal 2026 revenue grew 10%, guidance was raised, and the highest-growth engines are compounding above 30%. TurboTax Live — Intuit's AI-plus-expert model — is on t...
Read Article ›L3Harris shares have retreated nearly 20% from their 52-week high near $379, creating a compelling entry into what is shaping up as a multi-year earnings inflection. A record $40.7 billion backlog—which management describes as approximately two times revenue coverage—means the...
Read Article ›Boston Scientific shares have been cut roughly in half since mid-2025, driven by a guidance cut, competitive headwinds in electrophysiology, softening WATCHMAN procedure volumes, and a Class I pacemaker recall. Yet the company still posted 9.4% organic growth in Q1 2026, is on...
Read Article ›McKesson delivered FY2026 adjusted EPS of $39.11 (+18% year-over-year), beating its own long-range growth targets, and guided FY2027 EPS to $43.80–$44.60 (+12–14%). Q4 revenue of $96.3 billion missed consensus by ~5%, but the miss reflects branded drug price deflation and GLP-...
Read Article ›Jack Henry & Associates (JKHY) is a quality financial technology compounder whose stock has been punished even as its business accelerates. Shares trade near 52-week lows — down roughly 31% from their January high of $193.39 — despite record Q3 results, a surge in competitive ...
Read Article ›Summary T Mobile just delivered the strongest fundamental quarter in its history—accelerating account growth, raised guidance across every major metric, and a $3.6 billion increase to its 2026 shareholder return program. Yet the stock sits near $194, roughly 26% below its 52 w...
Read Article ›Stryker Corporation recently faced a significant cybersecurity incident that disrupted its global operations, particularly affecting its Microsoft environment. The company has been working diligently with third party experts and law enforcement to contain and neutralize the im...
Read Article ›While the market fixates on stale office narratives and near term refinancing woes, Newmark Group has quietly assembled the pieces for a compelling reopening story. The company just delivered record 2025 results—revenue up over 20%, adjusted EBITDA up over 26%—and guided for a...
Read Article ›